Aktuellt
SENASTE
Redeye saw a sales development that was stronger than expected. Costs were lower than expected in the quarter, where personnel and other operating costs improved. Paxman is still showing impressive growth, with a 39% increase in the quarter. Cost control compensates for a slightly lower gross margin than expected. We do not expect to do more than adjust for the sales and results beat in the quarter, with a marginal effect on our Base case. The quarters can be volatile. However, with a solid performance, our confidence in the case remains, and there is a long runway of potential growth ahead.
LÄS MER
